Dear all, we are offering a
* PhD position at the intersection of medicinal chemistry and structural biology *
at the Max Planck Institute for Developmental Biology in Tübingen, Germany.
We currently offer a project on the development of a novel anti-pathogenic drug for the
prevention and treatment of Salmonella infections. It aims at the inhibition of a transcription
factor that is crucial for the onset of infection, for which a first active compound has been
identified. The project is run within a multidisciplinary consortium including microbiologists,
medicinal chemists and structural biologists, which is fully funded by the Baden
Württemberg Stiftung. The main objectives of the PhD project are to unravel the structural
basis of the inhibition via X-ray crystallography and other biochemical and biophysical
methods, perform a fragment based drug discovery screen, and to participate in the
iterative structure-activity-relationship analysis of potential lead compounds in close
collaboration with our project partners.
More details can be found here:
Applications including a letter of motivation, detailed CV, a brief description of previous
work, as well as the names and contact information of two referees should be sent before
the 1st of June 2018 electronically to Marcus Hartmann
([log in to unmask]).
Dr. Marcus Hartmann
Max Planck Institute for Developmental Biology
Max-Planck-Ring 5, 72076 Tübingen, Germany. Phone: +49 (0)7071 601 323